Pfizer Stock Analysis

PFE Stock  USD 44.25  0.82  1.82%   
The small dip in market price for the last few months may encourage shareholders to take a closer look at the company as it is trading at a share price of 44.25 on 38,373,509 in trading volume. The company executives did not add much value to Pfizer investors in December. However, diversifying your holdings with Pfizer Inc or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.64. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Please check Your Equity Center.
  
The Pfizer stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pfizer is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Pfizer Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pfizer's ongoing operational relationships across important fundamental and technical indicators.

Pfizer Stock Analysis Notes

About 70.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 16.51. The company has Price/Earnings To Growth (PEG) ratio of 1.17. Pfizer Inc recorded earning per share (EPS) of 5.26. The entity last dividend was issued on the 26th of January 2023. The firm had 1054:1000 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Upcoming and Recent Events

Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report8th of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Pfizer Thematic Classifications

In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs
Drug manufacturing and delivery
Healthcare
Healthcare institutions that deliver medical services
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions

Pfizer Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zwj Investment Counsel IncCommon Shares42.6 K2.2 M
Zwj Investment Counsel IncCommon Shares39.5 K1.7 M
Zwj Investment Counsel IncCommon Shares44.4 K2.3 M
Zwj Investment Counsel IncCommon Shares41.2 K2.1 M
Zwj Investment Counsel IncCommon Shares41.2 K2.4 M
Zwj Investment Counsel IncCommon Shares41 K1.8 M
Zwj Investment Counsel IncCommon Shares40.2 K1.6 M
Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 252.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.3 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.4 %, which entails that for every 100 dollars of revenue, it generated 0.0 of operating income.
Last ReportedProjected for 2023
Return on Investment 17.04  13.57 
Return on Average Assets 11.79  9.41 
Return on Average Equity 28.17  22.63 
Return on Invested Capital 0.24  0.22 
Return on Sales 0.39  0.35 

Management Efficiency

The entity has Return on Asset of 0.1332 % which means that on every $100 spent on asset, it made $0.1332 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.3551 %, implying that it generated $0.3551 on every 100 dollars invested. Pfizer management efficiency ratios could be used to measure how well pfizer inc manages its routine affairs as well as how well it operates its assets and liabilities. As of January 27, 2023, Return on Investment is expected to decline to 13.57. In addition to that, Return on Average Assets is expected to decline to 9.41. Pfizer Tax Assets are projected to decrease significantly based on the last few years of reporting. The past year's Tax Assets were at 4.9 Billion. The current year Net Current Assets as percentage of Total Assets is expected to grow to 12.12, whereas Assets Non Current are forecasted to decline to about 117.1 B.
Last ReportedProjected for 2023
Book Value per Share 10.20  10.04 
Enterprise Value over EBIT 17.25  19.97 
Enterprise Value over EBITDA 12.96  13.91 
Price to Book Value 3.95  3.64 
Tangible Assets Book Value per Share 11.87  11.54 
Enterprise Value306.7 B295 B
Tangible Asset Value66.1 B70 B
Long Term Debt Total
36.2 B
Non Current Liabilities Total
61.3 B
Forward Dividend Yield
0.0367
Short Long Term Debt Total
37 B
Forward Dividend Rate
1.64

Technical Drivers

As of the 27th of January, Pfizer holds the Coefficient Of Variation of 9923.11, risk adjusted performance of 0.0145, and Semi Deviation of 1.64. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc information ratio, as well as the relationship between the value at risk and expected short fall to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 44.25 per share. Given that Pfizer has jensen alpha of (0.10), we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

Execute Study
The output start index for this execution was fourty-eight with a total number of output elements of thirteen. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pfizer middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pfizer Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

Pfizer Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pfizer Outstanding Bonds

Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pfizer Technical and Predictive Indicators

Pfizer Forecast Models

Pfizer time-series forecasting models is one of many Pfizer's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Pfizer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Last ReportedProjected for 2023
Operating Margin 22.93  21.28 
EBITDA Margin 32.40  30.77 
Gross Margin 71.40  82.57 
Profit Margin 24.34  22.76 

Current Pfizer Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
58.92Buy13Odds
Pfizer Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Analyst Advice Details

Pfizer Stock Analysis Indicators

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Begin Period Cash Flow1.8 B
Common Stock Shares Outstanding5.7 B
Total Stockholder Equity77.2 B
Total Cashflows From Investing Activities-22.5 B
Tax Provision1.9 B
Quarterly Earnings Growth Y O Y0.055
Property Plant And Equipment Net14.9 B
Retained Earnings103.4 B
Cash And Short Term Investments31.1 B
Retained Earnings Total Equity103.4 B
Cash1.9 B
Accounts Payable5.6 B
Net Debt35.1 B
50 Day M A49.4926
Total Current Liabilities42.7 B
Other Operating Expenses61.1 B
Non Current Assets Total121.8 B
Forward Price Earnings10.9649
Common Stock Total Equity473 M
Non Currrent Assets Other7.7 B
Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.055
Market Capitalization
253 B
Quarterly Revenue Growth
(0.06) 
Return On Assets
0.1332
Return On Equity
0.3551
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.